Published in Can J Gastroenterol on December 01, 2007
Why so late?!--delay in treatment of colorectal cancer is socially determined. Langenbecks Arch Surg (2010) 0.78
Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med (1993) 27.80
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet (1996) 20.53
Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet (1996) 18.89
The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med (2000) 13.19
Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst (1999) 8.08
Colorectal cancer screening. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2001) 4.69
A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ (1998) 4.44
Utilization of colonoscopy in the United States: results from a national consortium. Gastrointest Endosc (2005) 3.23
Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can (2003) 1.28
Patterns of use of flexible sigmoidoscopy, colonoscopy and gastroscopy: a population-based study in a Canadian province. Can J Gastroenterol (2004) 1.26
Receipt of colorectal testing prior to colorectal carcinoma diagnosis. Cancer (2005) 0.88
Gender differences in alcohol consumption and adverse drinking consequences: cross-cultural patterns. Addiction (2000) 3.85
Development and validation of a self-completed HIV symptom index. J Clin Epidemiol (2001) 3.28
Increasing incidence of paediatric inflammatory bowel disease in Ontario, Canada: evidence from health administrative data. Gut (2009) 2.62
Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43
Estimating the impact of alcohol consumption on survival for HIV+ individuals. AIDS Care (2007) 2.06
Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: a comparison with self-reported symptoms. Outcomes Committee of the AIDS Clinical Trials Group. J Acquir Immune Defic Syndr (1999) 1.74
Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc Natl Acad Sci U S A (1994) 1.73
General medical and psychiatric comorbidity among HIV-infected veterans in the post-HAART era. J Clin Epidemiol (2001) 1.67
On the emerging paradigm of drinking patterns and their social and health consequences. Addiction (1996) 1.60
Identification of HIV vaccine candidate peptides by screening random phage epitope libraries. Virology (1993) 1.60
Who provides gastrointestinal endoscopy in Canada? Can J Gastroenterol (2007) 1.58
Moderate drinking and health. Implications of recent evidence. Can Fam Physician (1997) 1.50
Extraesophageal associations of gastroesophageal reflux disease in children without neurologic defects. Gastroenterology (2001) 1.50
Clinical importance of provider-reported HIV symptoms compared with patient-report. Med Care (2001) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Costs of managing Helicobacter pylori-infected ulcer patients after initial therapy. Helicobacter (2001) 1.39
Smoking in the home: changing attitudes and current practices. Am J Public Health (1998) 1.32
Detecting, preventing, and managing patients' alcohol problems. Can Fam Physician (1994) 1.29
Determinants of suggestions for alcohol treatment. Addiction (1996) 1.24
Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers. Gut (2005) 1.22
Veterans aging cohort three-site study (VACS 3): overview and description. J Clin Epidemiol (2001) 1.22
Measuring the health burden of chronic disease and injury using health adjusted life expectancy and the Health Utilities Index. J Epidemiol Community Health (2002) 1.22
The effects of introducing or lowering legal per se blood alcohol limits for driving: an international review. Accid Anal Prev (2001) 1.21
Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endosc (2007) 1.13
Quantitative light microscopic detection of Enterocytozoon bieneusi in stool specimens: a longitudinal study of human immunodeficiency virus-infected microsporidiosis patients. J Clin Microbiol (1996) 1.11
Association of hypocholesterolaemia with hepatitis C virus infection in HIV-infected people. HIV Med (2004) 1.10
The effects of light to moderate drinking on cardiovascular diseases. J Intern Med (1999) 1.09
A reliability and validity analysis of an alcohol-related harm scale for surveys. J Stud Alcohol (1999) 1.01
Socioeconomic status & returning for a second screen in the Ontario breast screening program. Breast (2003) 1.00
Unusual esophageal ulcers containing enveloped viruslike particles in homosexual men. Gastroenterology (1986) 0.98
Cancer diagnostic assessment programs: standards for the organization of care in Ontario. Curr Oncol (2009) 0.97
Atypical mycobacterial infection of the gastrointestinal tract in AIDS patients. Am J Gastroenterol (1989) 0.96
A systematic review and meta-analysis of the prevalence of chlamydia, gonorrhoea and syphilis in incarcerated persons. Int J STD AIDS (2012) 0.95
A real-time audit of radiation therapy in a regional cancer center. Int J Radiat Oncol Biol Phys (1999) 0.94
Association between age and the utilization of radiotherapy in Ontario. Int J Radiat Oncol Biol Phys (2000) 0.92
Dyspepsia: how should we measure it? J Clin Epidemiol (1998) 0.92
Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens. Vaccine (1994) 0.91
The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med (1999) 0.89
Survival after necrotizing enterocolitis of leukemia treated with oral vancomycin. Gastroenterology (1981) 0.88
The management and outcome of bladder carcinoma in Ontario, 1982-1994. Cancer (2000) 0.87
Can the health utilities index measure change? Med Care (2001) 0.84
Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial. J Clin Epidemiol (1999) 0.82
AGA technical review: malnutrition and cachexia, chronic diarrhea, and hepatobiliary disease in patients with human immunodeficiency virus infection. Gastroenterology (1996) 0.81
Helicobacter pylori: when to test, when to treat. Ann Intern Med (1997) 0.81
Guidelines on sensible drinking. Addiction (1996) 0.80
Prospective study of fluconazole suspension for the treatment of oesophageal candidiasis in patients with AIDS. Aliment Pharmacol Ther (1995) 0.80
Alcohol and all-cause mortality: an overview. Novartis Found Symp (1998) 0.80
Clinical and socioeconomic determinants of health care use among HIV-infected patients in the Department of Veterans Affairs. Inquiry (2000) 0.79
Trends in hormonal management of prostate cancer: a population-based study in Ontario. Med Care (2001) 0.79
Safety and tolerance of trospium chloride in the high dose range. Arzneimittelforschung (1993) 0.79
A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer. Int J Radiat Oncol Biol Phys (1999) 0.79
Esophageal candidiasis in AIDS. Successful therapy with clotrimazole vaginal tablets taken by mouth. Dig Dis Sci (1991) 0.79
Gastric ulcers at endoscopy: brush, biopsy, or both? Am J Gastroenterol (1997) 0.78
Increased use of low anterior resection for veterans with rectal cancer. Aliment Pharmacol Ther (2005) 0.78
Effects of ischemia on metabolite concentrations in dog renal cortex. Ren Physiol (1982) 0.77
Comments concerning the use of dimethylsulfoxide as a solvent for studies of chlordecone neurotoxicity. Neurotoxicology (1982) 0.76
Because it's there: it was Mallory, not Hillary. Am J Gastroenterol (1994) 0.75
Surrogates, survival, and subversion. Hepatology (1997) 0.75
Effects on the Underlying Water Column by Extensive Floating Treatment Wetlands. J Environ Qual (2017) 0.75
Evolution of treatment for Hodgkin's disease: a population-based study of radiation therapy use and outcome. Clin Oncol (R Coll Radiol) (2003) 0.75
Why should gastroenterologists know about outcomes research? Gastrointest Endosc (1993) 0.75
Gallstones and bile duct cancer. Gastroenterology (1994) 0.75
Managing dyspepsia: is prompt endoscopy the way to go? Gastroenterology (1995) 0.75
Gastrointestinal bleeding in the critically ill: stress ulcer prophylaxis is not for everyone. Gastroenterology (1994) 0.75
Re: "Alcohol and mortality in Busselton, Western Australia". Am J Epidemiol (1994) 0.75
Pharmacokinetics and relative bioavailability of prajmalium bitartrate after single oral dosing. Arzneimittelforschung (1991) 0.75
Triethyltin-induced neuronal damage in neonatally exposed rats. Neurotoxicology (1986) 0.75
Prevalence of wasting in men infected with human immunodeficiency virus seeking routine medical care in an outpatient clinic. J Am Diet Assoc (1995) 0.75
A comparison of fat-free mass estimates in men infected with the human immunodeficiency virus. JPEN J Parenter Enteral Nutr (1995) 0.75
Long-term treatment of erosive esophagitis with omeprazole: does it work? Gastroenterology (1995) 0.75